Blockchain Registration Transaction Record

OYE Therapeutics Raises $5.5M to Advance Caffeine-Based Anesthesia Recovery Therapy

OYE Therapeutics raises $5.475M Series A funding for caffeine-based anesthesia recovery and opioid overdose therapy. Phase 1 clinical trial begins Q1 2026.

This development matters because it addresses two critical healthcare challenges: improving anesthesia recovery and combating opioid-induced respiratory depression. With opioid overdoses claiming thousands of lives annually and anesthesia recovery often being prolonged and uncomfortable, OYE's caffeine-based platform offers a novel approach that could accelerate patient recovery times and potentially save lives in overdose situations. The military's interest in this technology suggests applications beyond civilian healthcare, potentially benefiting service members in field medical situations. As healthcare systems seek more effective solutions for pain management and surgical recovery, this innovation represents a promising alternative to traditional approaches that often rely heavily on opioids with their associated risks.